These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31638456)

  • 21. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy.
    Xiao X; Mai G; Li S; Guo X; Zhang Q
    Biochem Biophys Res Commun; 2011 Jun; 409(2):181-6. PubMed ID: 21565171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of phenotype and CYP4V2 gene variants in two pedigrees affected with Bietti crystalline corneoretinal dystrophy].
    Xie Y; Bai Z; Sun Z; Gu L; Zhang X; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1340-1343. PubMed ID: 33306817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bietti's crystalline dystrophy in Nepalese patients: when genetic analysis supports clinical diagnosis.
    Suwal B; Bajimaya S; Bernstein PS
    Ophthalmic Genet; 2019 Aug; 40(4):390-392. PubMed ID: 31512983
    [No Abstract]   [Full Text] [Related]  

  • 24. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2.
    Li A; Jiao X; Munier FL; Schorderet DF; Yao W; Iwata F; Hayakawa M; Kanai A; Shy Chen M; Alan Lewis R; Heckenlively J; Weleber RG; Traboulsi EI; Zhang Q; Xiao X; Kaiser-Kupfer M; Sergeev YV; Hejtmancik JF
    Am J Hum Genet; 2004 May; 74(5):817-26. PubMed ID: 15042513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical coherence tomographic findings of crystal deposits in the lens and cornea in Bietti crystalline corneoretinopathy associated with mutation in the CYP4V2 gene.
    Chung JK; Shin JH; Jeon BR; Ki CS; Park TK
    Jpn J Ophthalmol; 2013 Sep; 57(5):447-50. PubMed ID: 23793346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical coherence tomography and optical coherence tomography angiography imaging in Bietti crystalline dystrophy.
    Tiryaki Demir S; Keles Yesiltas S; Kacar H; Akbas EB; Guven D
    Ophthalmic Genet; 2020 Apr; 41(2):194-197. PubMed ID: 32281452
    [No Abstract]   [Full Text] [Related]  

  • 27. PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti's Crystalline Dystrophy.
    Zhang Z; Yan B; Gao F; Li Q; Meng X; Chen P; Zhou L; Deng W; Li C; Xu W; Han S; Feng H; Li Y; Chen J; Yin Z; Liao C; Tse HF; Xu A; Lian Q
    Mol Ther; 2020 Dec; 28(12):2642-2661. PubMed ID: 32755565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype analysis of Bietti crystalline dystrophy in a family with the CYP4V2 Ile111Thr mutation.
    García-García GP; López-Garrido MP; Martínez-Rubio M; Moya-Moya MA; Belmonte-Martínez J; Escribano J
    Cornea; 2013 Jul; 32(7):1002-8. PubMed ID: 23538635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHOROIDAL AND RETINAL ATROPHY OF BIETTI CRYSTALLINE DYSTROPHY PATIENTS WITH CYP4V2 MUTATIONS COMPARED TO RETINITIS PIGMENTOSA PATIENTS WITH EYS MUTATIONS.
    Miyata M; Hata M; Ooto S; Ogino K; Gotoh N; Morooka S; Hasegawa T; Hirashima T; Sugahara M; Kuroda Y; Yamashiro K; Yoshimura N
    Retina; 2017 Jun; 37(6):1193-1202. PubMed ID: 27658286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes.
    Hata M; Ikeda HO; Iwai S; Iida Y; Gotoh N; Asaka I; Ikeda K; Isobe Y; Hori A; Nakagawa S; Yamato S; Arita M; Yoshimura N; Tsujikawa A
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3936-3941. PubMed ID: 29581279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystalline Hepatopathy Associated With Bietti Crystalline Dystrophy: A Striking Manifestation of Disordered Fatty Acid Metabolism.
    Dulken BW; Bahceci D; Leung LS; Mahajan VB; Choi WT; Tan SY
    Am J Surg Pathol; 2024 Sep; 48(9):1138-1145. PubMed ID: 38802997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy.
    Jiao X; Li A; Jin ZB; Wang X; Iannaccone A; Traboulsi EI; Gorin MB; Simonelli F; Hejtmancik JF
    Eur J Hum Genet; 2017 Apr; 25(4):461-471. PubMed ID: 28051075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel gene mutation in a patient with Bietti crystalline dystrophy without corneal deposits.
    Raoof N; Vincent AL
    Clin Exp Ophthalmol; 2017 May; 45(4):421-424. PubMed ID: 28097764
    [No Abstract]   [Full Text] [Related]  

  • 34. Choroidal Vasculature in Bietti Crystalline Dystrophy With CYP4V2 Mutations and in Retinitis Pigmentosa With EYS Mutations.
    Hirashima T; Miyata M; Ishihara K; Hasegawa T; Sugahara M; Ogino K; Yoshikawa M; Hata M; Kuroda Y; Muraoka Y; Ooto S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3871-3878. PubMed ID: 28763560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Compound Heterozygous Mutation in the CYP4V2 Gene in a Japanese Patient with Bietti's Crystalline Corneoretinal Dystrophy.
    Yokoi Y; Sato K; Aoyagi H; Takahashi Y; Yamagami M; Nakazawa M
    Case Rep Ophthalmol; 2011 Sep; 2(3):296-301. PubMed ID: 22087103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of Bietti Crystalline Dystrophy.
    Ng DS; Lai TY; Ng TK; Pang CP
    Asia Pac J Ophthalmol (Phila); 2016; 5(4):245-52. PubMed ID: 27228076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal imaging features and genetic findings in Bietti crystalline dystrophy.
    Wang W; Chen W; Bai X; Chen L
    BMC Ophthalmol; 2020 Aug; 20(1):331. PubMed ID: 32799831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy.
    Halford S; Liew G; Mackay DS; Sergouniotis PI; Holt R; Broadgate S; Volpi EV; Ocaka L; Robson AG; Holder GE; Moore AT; Michaelides M; Webster AR
    Ophthalmology; 2014 Jun; 121(6):1174-84. PubMed ID: 24480711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a human induced pluripotent stem cell line from a Bietti crystalline corneoretinal dystrophy patient with CYP4V2 mutations.
    Wu S; Zhu T; Sun Z; Wei X; Han X; Zou X; Sui R
    Stem Cell Res; 2021 May; 53():102330. PubMed ID: 33857831
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.